Essential role of E2-25K/Hip-2 in mediating amyloid-β neurotoxicity

Molecular Cell

Volumn 12, Issue 3, 2003, Pages 553-563

  Song, Sungmin ^a   Kim, So Young ^a   Hong, Yeon Mi ^a   Jo, Dong Gyu ^a   Lee, Joo Yong ^b   Shim, Sang Mi ^a   Chung, Chul Woong ^a   Seo, Soo Jung ^a   Yoo, Yung Joon ^a   Koh, Jae Young ^b   Lee, Min Chul ^c   Yates, Allan J ^d   Ichijo, Hidenori ^e   Jung, Yong Keun ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d OHIO STATE UNIVERSITY   (United States)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOENZYME; APOPTOSIS SIGNAL REGULATING KINASE 1; PROTEASOME; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION;

ANIMALIA;

EID: 0141638441     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2003.08.005     Document Type: Article

References (39)

1. Alves-Rodrigues A., Gregori L., Figueiredo-Pereira M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21:1998;516-520.
2. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555.
3. Bennett M.C., Bishop J.F., Leng Y., Chock P.B., Chase T.N., Mouradian M.M. Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274:1999;33855-33858.
4. Chen Z.J., Pickart C.M. A 25-kilodalton ubiquitin carrier protein (E2) catalyzes multiubiquitin chain synthesis via lysine 48 of ubiquitin. J. Biol. Chem. 266:1990;15698-15704.
5. Chen Z.J., Niles E.G., Pickart C.M. Isolation of a cDNA encoding a mammalian multiubiquitinating enzyme (E2-25K) and overexpression of the functional enzyme in Escherichia coli. J. Biol. Chem. 266:1991;15698-15704.
6. David H.S., Mok S.S., Bornstein J.C. Alzheimer's disease and Aβ toxicity. from top to bottom Nat. Rev. Neurosci. 2:2001;595-598.
7. de Diego J.L., Katz J.M., Marshall P., Gutierrez B., Manning J.E., Nussenzweig V., Gonzalez J. The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochemistry. 40:2001;1053-1062.
8. De Vrij F.M., Sluijs J.A., Gregori L., Fischer D.F., Hermens W.T., Goldgaber D., Verhaagen J., Van Leeuwen F.W., Hol E.M. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J. 15:2001;2680-2688.
9. Gregori L., Hainfeld J.F., Simon M.N., Goldgaber D. Binding of amyloid beta protein to the 20 S proteasome. J. Biol. Chem. 272:1997;58-62.
10. Guo Q., Fu W., Xie J., Luo H., Sells S.F., Geddes J.W., Bondada V., Rangnekar V.M., Mattson M.P. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4:1998;557-562.
11. Haldeman M.T., Xia G., Kasperek E.M., Pickart C.M. Structure and function of ubiquitin conjugating enzyme E2-25K. the tail is a core-dependent activity element Biochemistry. 36:1997;10526-10537.
12. Hardy J., Duff K., Hardy K.G., Perez-Tur J., Hutton M. Genetic dissection of Alzheimer's disease and related dementias. amyloid and its relationship to tau Nat. Neurosci. 1:1998;355-358.
13. Hetman M., Cavanaugh J.E., Kimelman D., Xia Z. Role of glycogen synthase kinase-3 beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20:2000;2567-2574.
14. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
15. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94.
16. Imaizumi K., Morihara T., Mori Y., Katayama T., Tsuda M., Furuyama T., Wanaka A., Takeda M., Tohyama M. The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J. Biol. Chem. 274:1999;7975-7981.
17. Jo D.G., Kim M.J., Choi Y.H., Kim I.K., Song S., Woo H.N., Chung C.W., Jung Y.K. Pro-apoptotic function of Calsenilin/DREAM/KChIP3. FASEB J. 15:2001;589-591.
18. Kalchman M.A., Graham R.K., Xia G., Koide H.B., Hodgson J.G., Graham K.C., Goldberg Y.P., Gietz R.D., Pickart C.M., Hayden M.R. Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J. Biol. Chem. 271:1996;19385-19394.
19. Kim K.W., Kim B.J., Chung C.W., Jo D.G., Kim I.K., Song Y.H., Kwon Y.K., Woo H.N., Jung Y.K. Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis. J. Cell. Biochem. 85:2002;334-345.
20. Lam Y.A., Pickart C.M., Alban A., Landon M., Jamieson C., Ramage R., Mayer R.J., Layfield R. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;9902-9906.
21. Lee S.J., Choi J.Y., Sung Y.M., Park H., Rhim H., Kang S. E3 ligase activity of RING finger proteins that interact with Hip-2, a human ubiquitin-conjugating enzyme. FEBS Lett. 503:2001;61-64.
22. Lindsten K., de Vrij F.M., Verhoef L.G., Fischer D.F., van Leeuwen F.W., Hol E.M., Masucci M.G., Dantuma N.P. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 157:2002;417-427.
23. Mastrandrea L.D., Kasperek E.M., Niles E.G., Pickart C.M. Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2-25K. Biochemistry. 37:1998;9784-9792.
24. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science. 235:1987;1641-1644.
25. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., Greenberg M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 21:2001;7551-7560.
26. Mukaetova-Ladinska E.B., Hurt J., Jakes R., Xuereb J., Honer W.G., Wischik C.M. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases. J. Neuropathol. Exp. Neurol. 59:2000;408-417.
27. Muller U., Grams A., Martinez-Noel G., Copeland N.G., Gilbert D.J., Jenkins N.A., Harbers K. Structure of the gene encoding the ubiquitin-conjugating enzyme Ubcm4, characterization of its promoter, and chromosome location. Gene. 224:1998;109-116.
28. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16:2002;1345-1355.
29. Perry G., Friedman R., Shaw G., Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. USA. 84:1987;3033-3036.
30. Piotrowski J., Beal R., Hoffman L., Wilkinson K.D., Cohen R.E., Pickart C.M. Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. J. Biol. Chem. 273:1997;23712-23721.
31. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R.et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
32. Savage M.J., Lin Y.G., Ciallella J.R., Flood D.G., Scott R.W. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22:2002;3376-3385.
33. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
34. Sinha S., Lieberburg I. Cellular mechanisms of beta-amyloid production and secretion. Proc. Natl. Acad. Sci. USA. 96:1999;11049-11053.
35. Snell R.G., MacMillan J.C., Cheadle J.P., Fenton I., Lazarou L.P., Davies P., MacDonald M.E., Gusella J.F., Harper P.S., Shaw D.J. Relationship between trinucleotide repeats expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4:1993;393-397.
36. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;7789-7793.
37. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., Neubauer A., Sonnemans M.A., Sluijs J.A., Koycu S., Ramdjielal R.D., Salehi A., Martens G.J.et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science. 279:1998;242-247.
38. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:2001;169-178.
39. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.